Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Income from Continuing Operations: 2017-2025

Historic Income from Continuing Operations for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $21.6 million.

  • Organogenesis Holdings' Income from Continuing Operations rose 74.90% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.7 million, marking a year-over-year decrease of 31.63%. This contributed to the annual value of -$9.9 million for FY2024, which is 299.35% down from last year.
  • As of Q3 2025, Organogenesis Holdings' Income from Continuing Operations stood at $21.6 million, which was up 329.63% from -$9.4 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Income from Continuing Operations ranged from a high of $51.0 million in Q4 2021 and a low of -$18.8 million during Q1 2025.
  • Its 3-year average for Income from Continuing Operations is -$1.1 million, with a median of -$2.1 million in 2024.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first spiked by 1,373.02% in 2023, then plummeted by 797.29% in 2025.
  • Over the past 5 years, Organogenesis Holdings' Income from Continuing Operations (Quarterly) stood at $51.0 million in 2021, then crashed by 85.32% to $7.5 million in 2022, then plummeted by 107.59% to -$568,000 in 2023, then slumped by 436.27% to -$3.0 million in 2024, then soared by 74.90% to $21.6 million in 2025.
  • Its Income from Continuing Operations was $21.6 million in Q3 2025, compared to -$9.4 million in Q2 2025 and -$18.8 million in Q1 2025.